Prana Surgical

Prana Surgical is an early-stage medical device innovator targeting a critical gap in the management of early-stage lung cancer and pulmonary nodules. Founded in 2016 by a team of thoracic surgeons and entrepreneurs, the company is developing the Prana System, a novel device intended to perform combined excision and ablation in a single, minimally invasive procedure. This approach aims to provide sufficient tissue for comprehensive diagnosis (including molecular and genetic analysis) while sparing healthy lung tissue, potentially reducing patient morbidity, healthcare costs, and diagnostic uncertainty. The technology is currently in the research and development phase and is not yet commercially available.

The Prana System™ is a minimally invasive, image-guided surgical platform designed to perform combined tissue excision and ablation in a single procedure. It aims to provide diagnostically sufficient tissue samples for molecular analysis while offering therapeutic potential, all while conserving healthy organ tissue.

Prana competes with existing diagnostic tools (CT-guided needle biopsies, bronchoscopic biopsies) and therapeutic standards (sublobar resection, lobectomy, standalone ablation). It may also face competition from other startups and large medtech companies developing next-generation robotic or navigational biopsy/therapy systems for the lung.